Millions Logo
home>Stocks>Divis Laboratories
Divis Laboratories
Divis LaboratoriesHealthcare
11,442.00+4,922.00 (+75.49%)in 1 year
As on 13 Nov 2026 at 15:55
Start SIP
52 Week Low: 5,647.5052 Week High: 11,824.00

Divis Laboratories Share Price Today

Divis Laboratories opened lower at ₹11,411.50, compared with its previous close of ₹11,485.00. In the last trading session on 13 Nov 2026, the stock traded between ₹11,350.50 and ₹11,645.50, with an average traded price of ₹11,497.77. It showed a sideways intraday trend.

Return calculator

Time Period

An investment of ₹10,000 made 5 years ago in Divis Laboratories is now worth

₹ 23,622.00

Giving a profit of

₹ 13,622.00 (136.22%)

Invest now

Note: Past profits do not guarantee future returns.

Analyst Overview

Buy

Rating by Refinitive from 26 Analysts

Buy
53.85%
Hold
19.23%
Sell
26.92%

Markets Today

Today's Change

-43.00 (-0.37%)

Day High

₹11,645.50

Day Low

₹11,350.50

Day Open

₹11,411.50

Prev Close

₹11,485.00

Volume

5,36,553

Value Traded

₹616.92 Cr

1W Return

12.83%

1M Return

21.39%

3M Return

33.05%

6M Return

72.22%

1Y Return

75.49%

Fundamentals

Market Cap (₹ Cr.)

3,03,749

PE Ratio

90.40

PB Ratio

16.89

Dividend Yield

0.26%

ROE

15.32%

ROCE

18.96%

Book Value (₹)

677.94

Face Value (₹)

2.00

EPS (TTM)

42.49

Industry PE

-

Beta

-

Debt to Equity

-

Investment Returns

1 Week

12.83%

6 Weeks

-

1 Month

21.39%

3 Months

33.05%

9 Months

85.00%

Financials

Yearly
Consolidated
All values in ₹ crores
70.32

Mar 21
90.74

Mar 22
81.12

Mar 23
81.84

Mar 24
97.12

Mar 25
110.67

Mar 26

Share Holding Pattern

Promoter51.88%
FII20.38%
DII19.17%
Retails & Others6.55%

Updates

13Nov

Divis Labs Q2FY27 net profit up 64%; peptide capacity expands

Net profit rose 64% YoY to ₹11,270 crore in Q2FY27. Revenue grew 35% YoY to ₹36,760 crore; EBITDA margin expanded to 42.60%. Custom synthesis contributed 62% of H1 revenue; generics 38%. Company installing multiple 3,000-litre SPPS lines to expand peptide capacity. Annual capex outlook maintained at ₹2,000 crore plus or minus 20%.

2 days ago
22Oct

Divis Laboratories shares worth ₹194.80 crore flag large trade on NSE

Approximately 2,13,394 shares of Divis Laboratories were flagged in a large-trade signal on NSE. Shares changed hands at ₹9,128.50, with a combined value of ₹194.80 crore. The signal is generated by a real-time trade-scanning system and is not a confirmed exchange-reported event. Buyer, seller, and broker identities are not available until the exchange discloses post-market reports.

24 days ago
30Sep

Divis Laboratories shares worth ₹23.49 crore change hands on BSE

A large-trade signal flagged approximately 24,994 shares of Divis Laboratories on BSE. Shares changed hands at ₹9400.00 per share, for a combined value of ₹23.49 crore. This is a real-time signal from trade-scanning activity, not a confirmed exchange-reported event. Official exchange disclosures on such activity are published only after market close.

1mo ago
6Aug

Divi's Laboratories posts 65% PAT surge in Q1FY27 on strong revenue growth

Divi's Laboratories posted a 65% YoY PAT surge to ₹902 crore in Q1FY27, with revenue rising 28% to ₹3,080 crore. The growth was supported by robust Custom Synthesis contributions and margin expansion, offsetting a forex loss of ₹7 crore compared to a gain last year.

3mo ago
2Aug

Divis Laboratories uploads Q1 FY27 earnings call audio for investors

Divis Laboratories Limited has made the audio recording of its Q1 FY27 earnings conference call available on its website. The call occurred on August 01, 2026, following a prior notice on July 24, 2026. The disclosure was filed with NSE and BSE under Regulation 30 of SEBI LODR, signed by Company Secretary M. Satish Choudhury.

3mo ago
31Jul

Divis Laboratories accepts retirement of two senior VPs

Divis Laboratories Ltd announced the retirement of Vice Presidents L. Ramesh Babu and D. Madhu Babu effective July 31, 2026. The filing, submitted under SEBI LODR Regulation 30, confirms both executives will cease to be Senior Management Personnel due to retirement, impacting procurement and projects divisions.

3mo ago

Top 5 Options

No contracts data.

Top Futures

ContractDays to ExpiryLTPChangeChange %VolumeOIOI Chg %
DIVISLAB NOV FUT1011,450.00-27.00-0.246,07,80055,92,3000.14
DIVISLAB DEC FUT4611,531.00-23.00-0.201,80,7007,29,10017.22
DIVISLAB JAN FUT7311,601.50-12.50-0.1119,80054,90014.14

Similar Stocks

StockLTPChange %Market Cap (Cr.)PE1Y Return
₹1,880.00-0.27%₹4,51,074.9741.20+8.54%
₹4,670.00-1.21%₹1,77,631.7985.50+22.10%
₹2,424.00+1.00%₹1,30,971.6897.10+145.03%
₹1,189.90-1.33%₹1,18,692.9828.00+25.07%
₹1,380.00-0.48%₹1,15,185.8842.00+12.23%
₹1,391.80-1.17%₹1,12,437.7439.90-8.39%
₹2,640.00+0.05%₹1,09,043.9048.10+16.30%
₹1,823.20+0.89%₹1,04,902.9026.00+54.04%
₹1,980.30-1.72%₹90,557.1317.60-2.64%
₹2,640.00-0.74%₹74,507.3151.60+42.87%
₹5,114.00-3.55%₹61,145.5430.50-11.33%
₹364.05-1.86%₹59,329.01177.50-10.31%